Skip to main content
Fig. 4 | Cardiovascular Diabetology

Fig. 4

From: DPP-4 inhibition with linagliptin ameliorates cognitive impairment and brain atrophy induced by transient cerebral ischemia in type 2 diabetic mice

Fig. 4

Effect of long-term linagliptin administration on escape latency of the hidden platform test (a), escape latency in the visible test (b), latency of the passive avoidance test (C) in db/db mice subjected to transient BCCAO. Abbreviations used are the same as in Fig. 4. Each value represents mean ± SEM (n = 10 in Sham, n = 10 in BCCAO + Veh, n = 11 in BCCAO + Lin)

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840